This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Merck has reported an increase in group net sales by 12.9% The growth in sales was driven by all regions and business sectors, particularly LifeScience. in group sales in fiscal 2022. resulted primarily from the development of the US dollar and the Chinese renminbi. in organic sales. organic rise.
Azbil Telstar announces the appointment of Rashedi Hassan as a Sales & Marketing Manager of the subsidiary of the company in Dhaka, Bangladesh. The post Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh appeared first on Pharma Mirror Magazine. Terrassa (Barcelona).
GSK has entered a strategic partnership with Wave LifeSciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. The discovery alliance, with a preliminary research period of four years, will aid GSK in progressing up to eight programmes and Wave to develop up to three programmes.
Viatris has signed definitive agreements to acquire Oyster Point Pharma and Famy LifeSciences in a deal totalling nearly $700m-$750m in cash to establish an ophthalmology franchise. A commercial-stage biopharmaceutical firm, Oyster Point discovers, develops and commercialises therapies for treating ophthalmic ailments.
Lifescience consulting can be a rewarding career and the job outlook is promising for the future. . Perhaps you have heard of lifescience consulting jobs but do not exactly know what type of work is involved, or the education and experience needed to become a lifescience consultant. Job Description.
The future of lifesciences CRM will be defined by rapid digital transformation and a focus on customer experience – and those who stick to old ways of working will be left in the dust, according to new research from Gartner. One of these companies is Omnipresence. I don’t think it’s possible to go back from this.
LifeSciences Council. Do you know about the LifeSciences Council (LSC)? The LSC has a website on Gov.uk, but the page says LifeSciences Council. A post from the director of health and lifesciences at Innovate UK, Richard J Hebdon, also bigged up the news before the Council met about four health missions.
But things are changing and women are becoming more influential in lifesciences VCs, with an increase in business going to all-female teams. The story was slightly different in lifesciences, however: all-female teams in biotech and pharma received 10% of funding compared with 7% for all-male”.
Consistency is a key factor in any successful lifescience content marketing strategy. Maintaining consistency throughout the content you develop is essential to establish credibility and loyalty. Let’s explore why and how consistency can play a vital role in the success of B2B lifescience content marketing.
Lifescience companies can position themselves as authoritative sources, create a community of loyal followers and influence purchasing decisions by leveraging content marketing strategies. With the aid of such excellent content, businesses can gradually move prospects through the sales funnel and convert them into paying customers.
This is an exciting opportunity to join pharmaphorum, contributing to our revenue targets, meeting new clients and supporting the development and launch of new offerings within the company’s leading international lifescience industry publications. Create and disseminate sales support materials. Competitor analysis.
Eversana’s suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training tools designed to improve the performance of sales representatives. The post Eversana aims athletes’ mental coaching at pharma sales reps appeared first on.
Even as some of the effects of COVID-19 have begun to wane, it’s a challenging time to be a life-sciencessales representative. Technology was supposed to bring on a new future for the sales interaction: greater insight into the customer, leading to better and more effective interactions. How can we do better?
Paula Parfitt discusses the importance of workplace diversity and how lifescience companies can build a thriving, diverse workforce. The lifesciences sector is an industry built on collaborative creativity and innovation, providing life saving solutions to some of modern science’s most important problems.
In an April survey conducted by Reuters and Omnipresence, 1,363 senior professionals mostly working in pharma (82.8%) in the EMEA region (73%) and biotech, medtech/device or consumer health companies reported on how lifesciences organisations were adapting to the ‘new normal’. That does not mean these capabilities are not available.
In 2022, lifesciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). Rarely are organisations able to view HCP relationships holistically – across clinical, medical, and sales – or reap the benefits of creating a unified understanding of the customer.
Venture capitalists have poured $42 billion into drug development over the past three years. Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8
Lifesciences commercial organizations can now forecast sales, predict churn, analyze brand propensity and launch new products with BirdzAI . P360 , a leading developer of technology for lifesciences companies, today announced major updates to its sales enablement platform BirdzAI.
In this blog, we delve into the recent sales data to highlight the top three best-selling eye drugs in 2023. Lets take a closer look at Eylea, Vabysmo and Lucentis the ophthalmology drugs that led the pack in recent sales figures. Related: Top 30 Drugs to Watch in 2024: Insights from 2023 Sales Data 1. billion, down from $1.50
billion Announced : February 2019 Closed : March 2020 In 2019, Danaher, a lifesciences and diagnostics innovator, acquired the Biopharma business from General Electric Companys (GE) LifeSciences division. Now operating as Cytiva, the business functions as a standalone company within Danahers LifeSciences segment.
In 2020, the US Food and Drug Administration (FDA) issued a Guidance for Industry recommending that sponsors include plans for developing age-appropriate formulations of drug products in instances where adult formulations may not be suitable for paediatric patients.
Biopharmaceutical firm Cingulate and lifesciences commercialisation firm Indegene have entered into a joint commercialisation deal for the former’s attention-deficit/hyperactivity disorder (ADHD) therapy CTx-1301 (dexmethylphenidate).
Lifesciences marketing has rapidly evolved to mirror that of consumer retail. It may not be surprising that the key to customer engagement optimisation, like many other processes within lifesciences operations, is orchestrated data management and analysis. Automatic HCP segmentation HCPs change segments regularly.
Two years ago, when Merck KGaA restructured, forming a new lifescience business, the goal was to maximize the enticing potential of its contract development and manufacturing organization (CDMO). |
As the COVID-19 situation develops, tax and regulatory specialists within the pharmaceutical & lifesciences industry are increasingly facing complex challenges. Der Beitrag PwC Pharma & LifeSciences Webinar: COVID-19 impact on the ITX and regulatory DNA – Thursday 28. Date Thursday 28.
A just-published report on the UK’s lifesciences sector “ought to ring alarm bells across government,” according to the Association of the British Pharmaceutical Industry (SBPI). The LifeSciences Competitiveness Indicators report shows that spending on lifesciences R&D was £2.7
Blueprint Medicines has entered strategic financing partnerships for up to $1.25bn with lifesciences-focused investors Sixth Street and Royalty Pharma. The funding will offer capital to extend Blueprint’s varied pipeline toward marketing as well as to continue seeking strategic and synergistic business development prospects.
And because of this, investors say previous sales forecasts by industry analysts may have been overly optimistic. The firm had initially estimated peak sales of CagriSema to reach $13 billion, but with the latest trial data, they slashed that projection to $7.25
Roche, a global leader in biotechnology and diagnostics, has entered into an exclusive collaboration and licensing agreement with Zealand Pharma, a specialist in innovative therapeutics, to co-develop and co-commercialize petrelintide as a potential foundational therapy for people with overweight and obesity. billion $1.4
Dave Hine is the senior director of sales and engineering at Greenphire. He has been reflecting on his time at DPharm and the collaborative approach to lifesciences.
Naperville, Illinois – October 24, 2023 : Cloudbyz, an innovative digital clinical research solutions provider, today announced a new partnership with SPAR Solutions who provide a complete range of customer engagement solutions covering sales, marketing, service, and communities.
They struggle to navigate a world in which the role of the sales representative is changing and the face-to-face interactions they relied on until now have declined in importance. While the number of drugs approved by the FDA has increased significantly in the last 5 years , average peak sales have declined since 2010.
The 2030 Consulting team provides high-caliber tactical contracting and strategic consulting for all aspects of business-to-business software solutions, from software sales and vendor selection to application development, implementation and managed services.
Maraoui said the company’s dermatology-focused sales force is “now preparing for a successful launch and to establish Emrosi as a new standard of care in the treatment of rosacea.” Journey Medical plans to make Emrosi available by early 2025 through dermatology clinics and pharmacies across the US.
billion gross value added (GVA) contribution to UK economic output – the largest for any lifescience sector – but it is important to “raise the level of ambition”, according to the MMIP. Notable examples include a pair of 10-year alliances with mRNA specialists Moderna and BioNTech.
As a result, the diversity of CFTR mutations presents significant challenges in developing therapies that can benefit all CF patients. Related: Top 30 Drugs to Watch in 2024: Insights from 2023 Sales Data Alyftrek will soon be available to US patients, offering a critical alternative to current therapies.
A field application scientist is a valuable member of any lifescience company due to their direct interaction with customers. An application scientist typically works for lifescience companies that manufacture laboratory tools or provide a service for laboratory use. Field Scientist Job Description.
From Bristol-Myers Squibbs monumental acquisition of Celgene to Pfizers recent purchase of Seagen, these deals illustrate the strategies and ambitions driving innovation in lifesciences. While the deal required regulatory divestitures, including the sale of Otezla (apremilast) to Amgen for $13.4
There are profound changes taking place in the area of lifescience research and development,” stated Swittons CEO and Founder Anupam Nandwana. Swittons is powered by the technology and expertise developed by P360. This has changed the very concept of what the lab is, and Swittons is a key part of that evolution.”.
Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. Currently, only 7% of companies say they are extremely satisfied with their organisation’s customer reference data’s ability to develop accurate analytics reports.
support the lifesciences industry across the UK and future innovation. Access and affordability activities will influence just how attractive the UK is to a global industry as well as how the UK supports lifesciences; buying their products is part of the overall equation. Pricing of new medicines.
Lifesciences commercial organizations can now forecast sales, predict churn, analyze brand propensity and launch new products with BirdzAI PISCATAWAY TOWNSHIP, N.J.–(BUSINESS
Nearly 70% of HCPs are now digital natives, with no interest in going back to pre-COVID sales engagement methods. Pre-COVID, digital sales engagement was mainly about emails – both reps-triggered emails that tended to be more personal and email campaigns prepared by HQ teams. Market pressures. Achieving digital excellence.
As a vertically integrated company, SHL Medical prides itself on being an end-to-end partner, offering in-house capabilities at every stage – from design, development and production to final assembly, labelling and packaging. They did a very good sales pitch – and it was the best decision we made.”.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content